The Nigeria Centre for Disease Control (NCDC) continues to play its leadership role as the national focal point for International Health Regulations (IHR) in the country. This includes the coordination of the implementation of the National Action Plan for Health Security (NAPHS), developed in November 2018.
The NAPHS is a five-year plan informed by the critical gaps identified following the Joint External Evaluation which was conducted in 2017. This was developed collaboratively with relevant Ministries, Departments and Agencies (MDAs) of the Federal Government of Nigeria. With 19 technical areas and over 600 activities, MDAs are currently at different levels of implementation.
In order to consolidate on the gains made, NCDC with support from Resolve to Save Lives (RTSL) conducted a three-day workshop from 24th -26th April 2019. The goals of the workshop were to:
a. Discuss the status of NAPHS implementation in respective MDAs
b. Train technical leads and focal points of MDAs on the functionality of NAPHS tracker tool; align on purpose, expectations and roles
c. Identify risks or barriers to effective use of the tracker
This important workshop is a critical step to ensure alignment across MDAs, given the variety of players within and outside the health sector, required for the implementation of the NAPHS. The new NAPHS tracker tool will provide an opportunity for all MDAs to communicate openly, understand progress across board and hold each other accountable.
Given the importance of inter-sectoral coordination, NCDC will continue to work with relevant MDAs, to ensure Nigerians are protected from public health threats, diseases and emergencies.
Summary of Incidents
* Ongoing Incidents are defined as confirmed cases where a national EOC or equivalent has been activated (EOC is currently activated for Lassa fever, Cerebrospinal meningitis and Measles)
Other incidents are those confirmed cases for which EOC is not activated
1. Information for this disease was retrieved from the Technical Working Group and Situation Reports
2. Case Fatality Rate (CFR) for this disease is reported for confirmed cases only
3. Information for this disease was retrieved from IDSR 002 data
4. CFR for this disease is reported for total cases i.e. suspected + confirmed
5. Information for sentinel influenza was retrieved from the laboratory
• There were 48 suspected cases of Lassa fever reported from 12 LGAs in seven States (Edo – 30, Ondo – 8, Bauchi -2, Gombe – 1, FCT – 1, Kogi - 2 & Plateau – 4). Three were laboratory confirmed and no death was recorded.
• In the reporting week 15, no new health care worker was affected
• Lassa fever Emergency operation center (EOC) continues to coordinate the response activities at all levels with on/offsite collaboration of MDAs and Partners
• Multi sectoral one health national rapid response teams deployed to Taraba and Bauchi states
• Distribution of response commodities- PPEs, Ribavirin (injection and tablets), beds, IEC materials, and SOPS distributed across priority states including FCT
• Support indigent patients with treatment cost through basic health care provision funds
• Dissemination of case management guidelines
• Review data to declare emergency phase of outbreak over.
• There were 44 suspected cases of Cerebrospinal Meningitis (CSM) reported from 44 LGAs in 15 States (Bauchi – 2, Borno – 1, Cross River – 3, Enugu – 1, FCT – 1, Gombe – 3, Kano – 2, Katsina – 4, Kebbi - 3, Nasarawa – 1, Niger – 2, Plateau – 1, Sokoto – 8, Yobe – 2 & Zamfara - 10). Of these, none was laboratory confirmed and one death was recorded
• Streptococcus pneumoniae serogroup (Spn) accounted for 42% of the positive cases and Neisseria meningitidis 46% of which NmX 14% and NmC 32%
• The National CSM Emergency Operation Center (EOC) is on response mode and meets
weekly to review the situation
• A case management, Lumber Puncture, sample and data management training were conducted in Katsina and Niger States.
• Training in other States on CSM case management, sample and data management
The last confirmed case of Yellow Fever was 27th of March 2019.
• A multiagency Yellow fever TWG is coordinating the response activities
• Off-site support is ongoing in Abia, Delta, Ondo, Imo and Osun states
• ICG request for reactive vaccination campaigns have been approved for Edo (5 LGAs), Ondo (7 LGAs) and Delta States (1 LGA)
• Development of National Guideline on Preparedness and Response is ongoing
• A follow up with the yellow fever reactive vaccination campaign pre-implementation activities in the approved states and their respective LGAs.
There were 91 suspected cases of cholera reported from eight LGAs in five States (Abia – 1, Bayelsa – 53, Borno – 2, Cross River – 32 & Kano – 2). None was laboratory confirmed and four deaths recorded.
• Cholera TWG is coordinating the activities in states in collaboration with FMWR and support from partners
• A sensitization workshop was conducted on WaSH for market women and religious leaders in Adamawa and Bauchi states
• First round of OCV campaign was conducted in Argungu LGA, Kebbi state and Michika LGA in Adamawa State on the 30th of March to 3rd of April, 2019
• A second round of OCV campaign is being planned
• Review of the Cholera advisory and disseminate ahead of the season.
Borno (958), Adamawa (180), Yobe (161) and Kaduna (124) states account for 75% of reported cases in week 15 of 2019
• The Measles Emergency Operation Center (EOC) continues to coordinate activities weekly
• Continued engagement with states for early submission of data
• Follow up with NPHCDA on plan for ICG request for Katsina and Yobe States
• Deploy RRT to support emergency response in Borno, Katsina, Adamawa and Yobe states.
Acute Flaccid Paralysis (AFP)
• The last reported case of polio in Nigeria was in August 2016
• As at 14th April 2019, no new case of WPV was recorded
• Active case search for AFP is being intensified with the goal to eliminate polio in Nigeria
• Intensify active AFP case search and continue to monitor progress being made to eliminate polio in Nigeria
National Influenza Sentinel Surveillance
• The predominant Influenza A subtype so far this year was A seasonal H3 19 (95%).
• The predominant Influenza B subtype so far this year was B not subtyped 2(100%).